These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1129844)

  • 1. The role of alloantibodies on in vivo growth of allografted tumor.
    Yutoku M; Kitagawa M
    Transplant Proc; 1975 Jun; 7(2):243-6. PubMed ID: 1129844
    [No Abstract]   [Full Text] [Related]  

  • 2. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
    Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
    J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-tumor effect of anti-dsDNA autoantibodies].
    Lü S; Zhang JP; Wu HS; Zheng XJ; Chu YW; Xiong SD
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):73-6. PubMed ID: 15946542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imuran-induced regression of plasma cell tumor MOPC-315.
    Schlossberg M; Hollander VP
    Cancer Res; 1973 Aug; 33(8):1953-6. PubMed ID: 4720804
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone dependency of murine endocrine tumors in vivo and in organ culture: a correlative study.
    Jacobs BB; Huseby RA
    J Natl Cancer Inst; 1972 Oct; 49(4):1205-12. PubMed ID: 4343476
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 9. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection.
    Takikawa O; Habara-Ohkubo A; Yoshida R
    J Immunol; 1990 Aug; 145(4):1246-50. PubMed ID: 2116480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of D-glucosamine and D-galactosamine on the uridine nucleotide concentration in mouse myeloid tumor (Graffi) and myeloma MOPC-21.
    Chelibonova-Lorer H
    Neoplasma; 1975; 22(1):23-7. PubMed ID: 1153035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
    Yuhas JM; Pazmino NH; Proctor JO; Toya RE
    Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR; Cerottini JC; Brunner KT
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract]   [Full Text] [Related]  

  • 19. SV40 protection in myeloma oncogenesis.
    Reinisch CL
    Nature; 1973 Apr; 242(5398):470-1. PubMed ID: 4349562
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.